
AIDDT offers an end-to-end drug design pipeline powered by AI to accelerate the development of effective treatments. The pipeline is modular and customizable and relies on deep learning models for generating, screening, and optimizing drug molecules. It can generate a large library of candidate molecules from limited input data, reducing manpower and cost. Positioned as a B2B platform for pharmaceutical and biotech companies, it enables scalable molecule design.

AIDDT offers an end-to-end drug design pipeline powered by AI to accelerate the development of effective treatments. The pipeline is modular and customizable and relies on deep learning models for generating, screening, and optimizing drug molecules. It can generate a large library of candidate molecules from limited input data, reducing manpower and cost. Positioned as a B2B platform for pharmaceutical and biotech companies, it enables scalable molecule design.